Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TheraB Medical is a U.S. neonatal medical device company focused on improving treatment for infant jaundice through wearable phototherapy. Its lead and flagship product, SnugLit, is a swaddle-style portable phototherapy device designed to treat neonatal jaundice while allowing parent-infant bonding and breastfeeding during therapy. The company developed the product with input from clinicians and parents and positioned it for use across hospital and home-care settings. TheraB raised seed financing from angel and venture investors to support FDA clearance and commercialization. In February 2026, the company announced its acquisition by Natus Sensory, following FDA 510(k) clearance for SnugLit in January 2026.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TheraB Medical.